Rank | Gene Set | Z-score |
---|---|---|
1 | * mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 9.73051083 |
2 | * energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.01783161 |
3 | * ATP synthesis coupled proton transport (GO:0015986) | 9.01783161 |
4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.44928036 |
5 | * respiratory electron transport chain (GO:0022904) | 7.99019723 |
6 | * electron transport chain (GO:0022900) | 7.77412429 |
7 | oxidative phosphorylation (GO:0006119) | 6.26727295 |
8 | tricarboxylic acid cycle (GO:0006099) | 5.47457443 |
9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.17160785 |
10 | * ATP biosynthetic process (GO:0006754) | 5.05487967 |
11 | protein complex biogenesis (GO:0070271) | 4.99811390 |
12 | regulation of mitochondrial translation (GO:0070129) | 4.96244994 |
13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.83860998 |
14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.83860998 |
15 | NADH dehydrogenase complex assembly (GO:0010257) | 4.83860998 |
16 | sarcomere organization (GO:0045214) | 4.78061518 |
17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.70309906 |
18 | * purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.67176035 |
19 | * purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.60987684 |
20 | NADH metabolic process (GO:0006734) | 4.58954703 |
21 | inner mitochondrial membrane organization (GO:0007007) | 4.56527075 |
22 | * hydrogen ion transmembrane transport (GO:1902600) | 4.55124669 |
23 | chaperone-mediated protein transport (GO:0072321) | 4.54948233 |
24 | proteasome assembly (GO:0043248) | 4.18332312 |
25 | * ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.16706563 |
26 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.13778723 |
27 | negative regulation of ligase activity (GO:0051352) | 4.11757497 |
28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.11757497 |
29 | cardiac myofibril assembly (GO:0055003) | 4.10857744 |
30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.07980615 |
31 | pseudouridine synthesis (GO:0001522) | 4.02999493 |
32 | quinone biosynthetic process (GO:1901663) | 4.00119210 |
33 | ubiquinone biosynthetic process (GO:0006744) | 4.00119210 |
34 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.99244894 |
35 | aerobic respiration (GO:0009060) | 3.98248534 |
36 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.91299057 |
37 | actin-myosin filament sliding (GO:0033275) | 3.89368959 |
38 | muscle filament sliding (GO:0030049) | 3.89368959 |
39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.88657400 |
40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.87226528 |
41 | regulation of oxidative phosphorylation (GO:0002082) | 3.85340813 |
42 | establishment of integrated proviral latency (GO:0075713) | 3.82022755 |
43 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.80962145 |
44 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.80962145 |
45 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.80962145 |
46 | * proton transport (GO:0015992) | 3.80502187 |
47 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.80144170 |
48 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.80144170 |
49 | heart process (GO:0003015) | 3.77804976 |
50 | heart contraction (GO:0060047) | 3.77804976 |
51 | * hydrogen transport (GO:0006818) | 3.73144170 |
52 | myofibril assembly (GO:0030239) | 3.72823901 |
53 | * nucleoside triphosphate biosynthetic process (GO:0009142) | 3.72647132 |
54 | establishment of protein localization to mitochondrion (GO:0072655) | 3.72015164 |
55 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.71955144 |
56 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.71351707 |
57 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.71351707 |
58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.70616775 |
59 | protein targeting to mitochondrion (GO:0006626) | 3.70588289 |
60 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.67213613 |
61 | cardiac muscle contraction (GO:0060048) | 3.65377443 |
62 | ribosomal small subunit biogenesis (GO:0042274) | 3.65091280 |
63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.64845113 |
64 | viral transcription (GO:0019083) | 3.62191018 |
65 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.59409932 |
66 | spliceosomal snRNP assembly (GO:0000387) | 3.58851893 |
67 | * purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.58814371 |
68 | * purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.58814371 |
69 | protein neddylation (GO:0045116) | 3.57999881 |
70 | * mitochondrial transport (GO:0006839) | 3.55970052 |
71 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.55132708 |
72 | translational termination (GO:0006415) | 3.53813908 |
73 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.53682028 |
74 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.53175364 |
75 | protein localization to mitochondrion (GO:0070585) | 3.52567698 |
76 | regulation of coenzyme metabolic process (GO:0051196) | 3.51295678 |
77 | regulation of cofactor metabolic process (GO:0051193) | 3.51295678 |
78 | ubiquinone metabolic process (GO:0006743) | 3.49504840 |
79 | regulation of cellular respiration (GO:0043457) | 3.47322827 |
80 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.46229826 |
81 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.43705443 |
82 | respiratory chain complex IV assembly (GO:0008535) | 3.43414777 |
83 | positive regulation of ligase activity (GO:0051351) | 3.43301549 |
84 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.43287449 |
85 | cardiac muscle cell development (GO:0055013) | 3.43162175 |
86 | GTP biosynthetic process (GO:0006183) | 3.36915466 |
87 | ribosomal small subunit assembly (GO:0000028) | 3.34119428 |
88 | cytochrome complex assembly (GO:0017004) | 3.34110509 |
89 | translational initiation (GO:0006413) | 3.32791418 |
90 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32701229 |
91 | DNA deamination (GO:0045006) | 3.32495970 |
92 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.28560366 |
93 | cullin deneddylation (GO:0010388) | 3.26907981 |
94 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.26518746 |
95 | peptidyl-histidine modification (GO:0018202) | 3.26098686 |
96 | translation (GO:0006412) | 3.25962445 |
97 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.25360554 |
98 | rRNA processing (GO:0006364) | 3.25357981 |
99 | cellular respiration (GO:0045333) | 3.24697730 |
100 | succinate metabolic process (GO:0006105) | 3.24407279 |
101 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.23658043 |
102 | viral life cycle (GO:0019058) | 3.22097035 |
103 | ribosomal large subunit biogenesis (GO:0042273) | 3.21749276 |
104 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.21319042 |
105 | translational elongation (GO:0006414) | 3.21044248 |
106 | regulation of relaxation of muscle (GO:1901077) | 3.19540965 |
107 | cellular protein complex disassembly (GO:0043624) | 3.19033749 |
108 | DNA strand elongation (GO:0022616) | 3.18139115 |
109 | termination of RNA polymerase III transcription (GO:0006386) | 3.17745100 |
110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.17745100 |
111 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.17740967 |
112 | maturation of SSU-rRNA (GO:0030490) | 3.17188813 |
113 | oxaloacetate metabolic process (GO:0006107) | 3.16911562 |
114 | establishment of viral latency (GO:0019043) | 3.16671117 |
115 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.16224037 |
116 | cotranslational protein targeting to membrane (GO:0006613) | 3.15296659 |
117 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.15009662 |
118 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.14923620 |
119 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.12703547 |
120 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.11979167 |
121 | * generation of precursor metabolites and energy (GO:0006091) | 3.11705390 |
122 | cardiac cell development (GO:0055006) | 3.11524971 |
123 | protein targeting to ER (GO:0045047) | 3.11356437 |
124 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10913843 |
125 | rRNA metabolic process (GO:0016072) | 3.10661028 |
126 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.10341244 |
127 | regulation of ligase activity (GO:0051340) | 3.09399338 |
128 | regulation of cellular amine metabolic process (GO:0033238) | 3.08804863 |
129 | actin-mediated cell contraction (GO:0070252) | 3.08473120 |
130 | rRNA modification (GO:0000154) | 3.07616504 |
131 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.07220374 |
132 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.07220374 |
133 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.05805594 |
134 | protein-cofactor linkage (GO:0018065) | 3.04149422 |
135 | protein deneddylation (GO:0000338) | 3.03025692 |
136 | cellular component biogenesis (GO:0044085) | 3.02991236 |
137 | * ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.01879992 |
138 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.00901269 |
139 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.00264895 |
140 | regulation of actin filament-based movement (GO:1903115) | 2.99219447 |
141 | protein localization to endoplasmic reticulum (GO:0070972) | 2.97418004 |
142 | UTP biosynthetic process (GO:0006228) | 2.96062678 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.05633502 |
2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.26555016 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.21862759 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.11804105 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.02722442 |
6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.94377723 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.91852287 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.71552666 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.70611271 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.67264352 |
11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.63066701 |
12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.57199175 |
13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.43336112 |
14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.03072866 |
15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03070456 |
16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.78327600 |
17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.71517115 |
18 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.67228394 |
19 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.66615708 |
20 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.63817447 |
21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.62926263 |
22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.60789264 |
23 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.56433531 |
24 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.54678382 |
25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.33004340 |
26 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.32152550 |
27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25922767 |
28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.20137757 |
29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15350244 |
30 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.98425400 |
31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.88905570 |
32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.85932028 |
33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85673396 |
34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.83577433 |
35 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.79578665 |
36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73998785 |
37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.72425453 |
38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56256012 |
39 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54304102 |
40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54102758 |
41 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47731087 |
42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43990795 |
43 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43432033 |
44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43312953 |
45 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41209671 |
46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41086396 |
47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39237403 |
48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36461799 |
49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35561788 |
50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35198233 |
51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35052142 |
52 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34156898 |
53 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.33151401 |
54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27302516 |
55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25257427 |
56 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24838603 |
57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24599166 |
58 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21295025 |
59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.19840696 |
60 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17430613 |
61 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.16428606 |
62 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15426326 |
63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15068701 |
64 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13276593 |
65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09271816 |
66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08059033 |
67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08020491 |
68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06204292 |
69 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06190032 |
70 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.04386724 |
71 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03315768 |
72 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02681516 |
73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.01429204 |
74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98586409 |
75 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97312609 |
76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96490916 |
77 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94503963 |
78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93712622 |
79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93041166 |
80 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92768381 |
81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92551789 |
82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92411250 |
83 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91908465 |
84 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.89983220 |
85 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88074609 |
86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87394880 |
87 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86446348 |
88 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.85377086 |
89 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.85354556 |
90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83631348 |
91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82266522 |
92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82111088 |
93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81356999 |
94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81323763 |
95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.80731780 |
96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79019866 |
97 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78661779 |
98 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.78529769 |
99 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.77861331 |
100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76936825 |
101 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75575454 |
102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.74291098 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.73754199 |
104 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.73512475 |
105 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.72969006 |
106 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72243925 |
107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69039086 |
108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.68965068 |
109 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.68766853 |
110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68601684 |
111 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66933659 |
112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.66829031 |
113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.66395419 |
114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66248617 |
115 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.66186970 |
116 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.65378067 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.49212764 |
2 | MP0003646_muscle_fatigue | 5.45302204 |
3 | MP0004084_abnormal_cardiac_muscle | 4.54555839 |
4 | MP0004215_abnormal_myocardial_fiber | 4.30235278 |
5 | MP0000751_myopathy | 4.27087249 |
6 | MP0008058_abnormal_DNA_repair | 3.65411858 |
7 | MP0004036_abnormal_muscle_relaxation | 3.45258121 |
8 | MP0000749_muscle_degeneration | 3.38440049 |
9 | MP0005330_cardiomyopathy | 3.34508608 |
10 | MP0006036_abnormal_mitochondrial_physio | 3.33642487 |
11 | MP0010094_abnormal_chromosome_stability | 3.20657226 |
12 | MP0003137_abnormal_impulse_conducting | 2.69673716 |
13 | MP0006035_abnormal_mitochondrial_morpho | 2.67459068 |
14 | MP0000372_irregular_coat_pigmentation | 2.54161037 |
15 | MP0003111_abnormal_nucleus_morphology | 2.46946396 |
16 | MP0002972_abnormal_cardiac_muscle | 2.41560867 |
17 | MP0000750_abnormal_muscle_regeneration | 2.40065490 |
18 | MP0003806_abnormal_nucleotide_metabolis | 2.26313083 |
19 | MP0001529_abnormal_vocalization | 2.23587484 |
20 | MP0009697_abnormal_copulation | 2.15620905 |
21 | MP0008775_abnormal_heart_ventricle | 2.10012294 |
22 | MP0004087_abnormal_muscle_fiber | 2.08900989 |
23 | MP0005620_abnormal_muscle_contractility | 2.06247987 |
24 | MP0009379_abnormal_foot_pigmentation | 2.05729749 |
25 | MP0004484_altered_response_of | 2.04527288 |
26 | MP0005385_cardiovascular_system_phenoty | 2.02376154 |
27 | MP0001544_abnormal_cardiovascular_syste | 2.02376154 |
28 | MP0008007_abnormal_cellular_replicative | 2.01582370 |
29 | MP0002106_abnormal_muscle_physiology | 1.99191583 |
30 | MP0002269_muscular_atrophy | 1.97731628 |
31 | MP0004145_abnormal_muscle_electrophysio | 1.93680452 |
32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81610304 |
33 | MP0002332_abnormal_exercise_endurance | 1.78971228 |
34 | MP0003880_abnormal_central_pattern | 1.74067644 |
35 | MP0004085_abnormal_heartbeat | 1.74052950 |
36 | MP0002938_white_spotting | 1.72989039 |
37 | MP0006138_congestive_heart_failure | 1.72571665 |
38 | MP0006292_abnormal_olfactory_placode | 1.71072436 |
39 | MP0000747_muscle_weakness | 1.66922821 |
40 | MP0006276_abnormal_autonomic_nervous | 1.63181438 |
41 | MP0005369_muscle_phenotype | 1.59193220 |
42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55335829 |
43 | MP0010630_abnormal_cardiac_muscle | 1.50668953 |
44 | MP0005266_abnormal_metabolism | 1.50274418 |
45 | MP0003011_delayed_dark_adaptation | 1.49376305 |
46 | MP0002127_abnormal_cardiovascular_syste | 1.45839196 |
47 | MP0000759_abnormal_skeletal_muscle | 1.45787034 |
48 | MP0004043_abnormal_pH_regulation | 1.42378049 |
49 | MP0003693_abnormal_embryo_hatching | 1.41528286 |
50 | MP0008789_abnormal_olfactory_epithelium | 1.35017709 |
51 | MP0008995_early_reproductive_senescence | 1.29530814 |
52 | MP0004957_abnormal_blastocyst_morpholog | 1.28619655 |
53 | MP0004142_abnormal_muscle_tone | 1.27273326 |
54 | MP0003828_pulmonary_edema | 1.25448040 |
55 | MP0005408_hypopigmentation | 1.22064247 |
56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20167017 |
57 | MP0002102_abnormal_ear_morphology | 1.18510847 |
58 | MP0001905_abnormal_dopamine_level | 1.18436838 |
59 | MP0003186_abnormal_redox_activity | 1.17769035 |
60 | MP0003718_maternal_effect | 1.17444672 |
61 | MP0002160_abnormal_reproductive_system | 1.15892825 |
62 | MP0004233_abnormal_muscle_weight | 1.15817649 |
63 | MP0004130_abnormal_muscle_cell | 1.13876983 |
64 | MP0005645_abnormal_hypothalamus_physiol | 1.13378218 |
65 | MP0005084_abnormal_gallbladder_morpholo | 1.12149639 |
66 | MP0004147_increased_porphyrin_level | 1.06046316 |
67 | MP0008877_abnormal_DNA_methylation | 1.02838361 |
68 | MP0005075_abnormal_melanosome_morpholog | 1.01699618 |
69 | MP0003941_abnormal_skin_development | 0.99883597 |
70 | MP0002736_abnormal_nociception_after | 0.99567781 |
71 | MP0002822_catalepsy | 0.98131623 |
72 | MP0001727_abnormal_embryo_implantation | 0.96933714 |
73 | MP0001984_abnormal_olfaction | 0.96740684 |
74 | MP0003123_paternal_imprinting | 0.96388627 |
75 | MP0005379_endocrine/exocrine_gland_phen | 0.95968413 |
76 | MP0004924_abnormal_behavior | 0.95652668 |
77 | MP0005386_behavior/neurological_phenoty | 0.95652668 |
78 | MP0003195_calcinosis | 0.95642002 |
79 | MP0003136_yellow_coat_color | 0.92902457 |
80 | MP0000358_abnormal_cell_content/ | 0.90962315 |
81 | MP0005646_abnormal_pituitary_gland | 0.90101911 |
82 | MP0002210_abnormal_sex_determination | 0.90003076 |
83 | MP0005451_abnormal_body_composition | 0.89507593 |
84 | MP0005360_urolithiasis | 0.89348210 |
85 | MP0000230_abnormal_systemic_arterial | 0.87696721 |
86 | MP0005332_abnormal_amino_acid | 0.87621174 |
87 | MP0005165_increased_susceptibility_to | 0.86320789 |
88 | MP0001440_abnormal_grooming_behavior | 0.86052956 |
89 | MP0008932_abnormal_embryonic_tissue | 0.85858663 |
90 | MP0002132_abnormal_respiratory_system | 0.84404349 |
91 | MP0000350_abnormal_cell_proliferation | 0.82980526 |
92 | MP0003950_abnormal_plasma_membrane | 0.80530236 |
93 | MP0000313_abnormal_cell_death | 0.80453187 |
94 | MP0001968_abnormal_touch/_nociception | 0.79682573 |
95 | MP0009046_muscle_twitch | 0.79570685 |
96 | MP0005389_reproductive_system_phenotype | 0.79037678 |
97 | MP0001929_abnormal_gametogenesis | 0.77401541 |
98 | MP0002638_abnormal_pupillary_reflex | 0.77360656 |
99 | MP0002735_abnormal_chemical_nociception | 0.75807086 |
100 | MP0005410_abnormal_fertilization | 0.75503988 |
101 | MP0001764_abnormal_homeostasis | 0.75168196 |
102 | MP0002272_abnormal_nervous_system | 0.73352935 |
103 | MP0002095_abnormal_skin_pigmentation | 0.73311517 |
104 | MP0005253_abnormal_eye_physiology | 0.73125858 |
105 | MP0010030_abnormal_orbit_morphology | 0.73124220 |
106 | MP0005376_homeostasis/metabolism_phenot | 0.72422183 |
107 | MP0000653_abnormal_sex_gland | 0.72287855 |
108 | MP0001145_abnormal_male_reproductive | 0.72245263 |
109 | MP0005499_abnormal_olfactory_system | 0.71477741 |
110 | MP0005394_taste/olfaction_phenotype | 0.71477741 |
111 | MP0003315_abnormal_perineum_morphology | 0.70628862 |
112 | MP0005551_abnormal_eye_electrophysiolog | 0.70329208 |
113 | MP0001881_abnormal_mammary_gland | 0.70016291 |
114 | MP0005636_abnormal_mineral_homeostasis | 0.69132861 |
115 | MP0002139_abnormal_hepatobiliary_system | 0.69121689 |
116 | MP0002277_abnormal_respiratory_mucosa | 0.67501927 |
117 | MP0004510_myositis | 0.66366049 |
118 | MP0001730_embryonic_growth_arrest | 0.66060762 |
119 | MP0009745_abnormal_behavioral_response | 0.65593310 |
120 | MP0005395_other_phenotype | 0.65135221 |
121 | MP0002064_seizures | 0.64318383 |
122 | MP0000343_altered_response_to | 0.63470388 |
123 | MP0005083_abnormal_biliary_tract | 0.63252174 |
124 | MP0001293_anophthalmia | 0.62992435 |
125 | MP0008873_increased_physiological_sensi | 0.62224173 |
126 | MP0005085_abnormal_gallbladder_physiolo | 0.61668890 |
127 | MP0005535_abnormal_body_temperature | 0.60842284 |
128 | MP0005319_abnormal_enzyme/_coenzyme | 0.60211107 |
129 | MP0008872_abnormal_physiological_respon | 0.59448641 |
130 | MP0006072_abnormal_retinal_apoptosis | 0.57213139 |
131 | MP0002909_abnormal_adrenal_gland | 0.56605591 |
132 | MP0001485_abnormal_pinna_reflex | 0.55789828 |
133 | MP0003656_abnormal_erythrocyte_physiolo | 0.54635242 |
134 | MP0002067_abnormal_sensory_capabilities | 0.53221369 |
135 | MP0002163_abnormal_gland_morphology | 0.52594855 |
136 | MP0008004_abnormal_stomach_pH | 0.50938107 |
137 | MP0003122_maternal_imprinting | 0.50359350 |
138 | MP0002234_abnormal_pharynx_morphology | 0.50319379 |
139 | MP0001970_abnormal_pain_threshold | 0.50086357 |
140 | MP0000266_abnormal_heart_morphology | 0.49091378 |
141 | MP0003077_abnormal_cell_cycle | 0.47051859 |
142 | MP0003786_premature_aging | 0.46474340 |
143 | MP0005670_abnormal_white_adipose | 0.45904664 |
144 | MP0001756_abnormal_urination | 0.45629189 |
145 | MP0003635_abnormal_synaptic_transmissio | 0.45441333 |
146 | MP0000013_abnormal_adipose_tissue | 0.45376825 |
147 | MP0002876_abnormal_thyroid_physiology | 0.44895656 |
148 | MP0002572_abnormal_emotion/affect_behav | 0.44827594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 7.07215476 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.67216689 |
3 | Mitochondrial inheritance (HP:0001427) | 6.20322624 |
4 | Acute encephalopathy (HP:0006846) | 6.03110603 |
5 | Progressive macrocephaly (HP:0004481) | 5.88922116 |
6 | Hepatocellular necrosis (HP:0001404) | 5.67196791 |
7 | Increased CSF lactate (HP:0002490) | 5.55706194 |
8 | Hepatic necrosis (HP:0002605) | 5.45565953 |
9 | Sudden death (HP:0001699) | 4.97955009 |
10 | Cerebral edema (HP:0002181) | 4.66879480 |
11 | Increased hepatocellular lipid droplets (HP:0006565) | 4.42940518 |
12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.26096776 |
13 | Lactic acidosis (HP:0003128) | 4.18780302 |
14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.18259239 |
15 | Increased intramyocellular lipid droplets (HP:0012240) | 4.16646161 |
16 | Exercise intolerance (HP:0003546) | 4.16370016 |
17 | Respiratory failure (HP:0002878) | 4.12792724 |
18 | Ventricular tachycardia (HP:0004756) | 4.01596937 |
19 | Calf muscle hypertrophy (HP:0008981) | 4.00301881 |
20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.00280548 |
21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.00280548 |
22 | Increased muscle lipid content (HP:0009058) | 3.85089707 |
23 | Increased serum lactate (HP:0002151) | 3.84085997 |
24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.80899387 |
25 | Increased serum pyruvate (HP:0003542) | 3.73794112 |
26 | Abnormality of glycolysis (HP:0004366) | 3.73794112 |
27 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.64380429 |
28 | Palpitations (HP:0001962) | 3.59207859 |
29 | Renal Fanconi syndrome (HP:0001994) | 3.41300245 |
30 | Optic disc pallor (HP:0000543) | 3.38231390 |
31 | Atrial fibrillation (HP:0005110) | 3.24126775 |
32 | Exercise-induced myalgia (HP:0003738) | 3.13226386 |
33 | Supraventricular tachycardia (HP:0004755) | 3.11708703 |
34 | Leukodystrophy (HP:0002415) | 3.07086151 |
35 | Primary atrial arrhythmia (HP:0001692) | 3.06326000 |
36 | Exercise-induced muscle cramps (HP:0003710) | 3.05934707 |
37 | Muscle fiber splitting (HP:0003555) | 3.05064450 |
38 | Lipoatrophy (HP:0100578) | 3.03855688 |
39 | Type I transferrin isoform profile (HP:0003642) | 3.01933631 |
40 | Supraventricular arrhythmia (HP:0005115) | 3.00960172 |
41 | Abnormality of the calf musculature (HP:0001430) | 3.00835820 |
42 | Syncope (HP:0001279) | 2.98277547 |
43 | Myoglobinuria (HP:0002913) | 2.94654132 |
44 | Reticulocytopenia (HP:0001896) | 2.94076174 |
45 | CNS demyelination (HP:0007305) | 2.92246447 |
46 | Ventricular fibrillation (HP:0001663) | 2.89241540 |
47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.88873530 |
48 | Exertional dyspnea (HP:0002875) | 2.85061432 |
49 | Pheochromocytoma (HP:0002666) | 2.83109618 |
50 | Ragged-red muscle fibers (HP:0003200) | 2.82368378 |
51 | Lethargy (HP:0001254) | 2.80722626 |
52 | Neuroendocrine neoplasm (HP:0100634) | 2.75018969 |
53 | Respiratory difficulties (HP:0002880) | 2.74056595 |
54 | Rhabdomyolysis (HP:0003201) | 2.73696923 |
55 | Testicular atrophy (HP:0000029) | 2.71471975 |
56 | Abnormality of alanine metabolism (HP:0010916) | 2.66873264 |
57 | Hyperalaninemia (HP:0003348) | 2.66873264 |
58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.66873264 |
59 | Aplastic anemia (HP:0001915) | 2.65197533 |
60 | Emotional lability (HP:0000712) | 2.63446949 |
61 | Dilated cardiomyopathy (HP:0001644) | 2.61538067 |
62 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61190507 |
63 | Dicarboxylic aciduria (HP:0003215) | 2.57972322 |
64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57972322 |
65 | Prolonged QT interval (HP:0001657) | 2.55855028 |
66 | Conjunctival hamartoma (HP:0100780) | 2.49463418 |
67 | Myotonia (HP:0002486) | 2.49103133 |
68 | Abnormal number of erythroid precursors (HP:0012131) | 2.46279644 |
69 | Reduced antithrombin III activity (HP:0001976) | 2.42697856 |
70 | Ventricular arrhythmia (HP:0004308) | 2.41728976 |
71 | Glycosuria (HP:0003076) | 2.41220052 |
72 | Abnormality of urine glucose concentration (HP:0011016) | 2.41220052 |
73 | Progressive external ophthalmoplegia (HP:0000590) | 2.41045224 |
74 | Abnormal protein glycosylation (HP:0012346) | 2.40953157 |
75 | Abnormal glycosylation (HP:0012345) | 2.40953157 |
76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40953157 |
77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40953157 |
78 | Bundle branch block (HP:0011710) | 2.37416918 |
79 | Progressive muscle weakness (HP:0003323) | 2.33596041 |
80 | EMG: myopathic abnormalities (HP:0003458) | 2.31481009 |
81 | Degeneration of anterior horn cells (HP:0002398) | 2.30023939 |
82 | Abnormality of the anterior horn cell (HP:0006802) | 2.30023939 |
83 | Subaortic stenosis (HP:0001682) | 2.29614247 |
84 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29614247 |
85 | Ketoacidosis (HP:0001993) | 2.20546345 |
86 | Pancytopenia (HP:0001876) | 2.18010450 |
87 | Amniotic constriction ring (HP:0009775) | 2.17802429 |
88 | Abnormality of placental membranes (HP:0011409) | 2.17802429 |
89 | Oral leukoplakia (HP:0002745) | 2.16316090 |
90 | Right ventricular cardiomyopathy (HP:0011663) | 2.15619046 |
91 | Abnormality of renal resorption (HP:0011038) | 2.15460333 |
92 | Cerebral hypomyelination (HP:0006808) | 2.15453611 |
93 | Abnormal EKG (HP:0003115) | 2.14741640 |
94 | X-linked dominant inheritance (HP:0001423) | 2.10642749 |
95 | Hyperphosphaturia (HP:0003109) | 2.08238214 |
96 | Areflexia of lower limbs (HP:0002522) | 2.07489861 |
97 | Left ventricular hypertrophy (HP:0001712) | 2.07098712 |
98 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06287411 |
99 | Heart block (HP:0012722) | 2.05520213 |
100 | Vomiting (HP:0002013) | 2.04859403 |
101 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04415621 |
102 | Gliosis (HP:0002171) | 2.04327802 |
103 | Microvesicular hepatic steatosis (HP:0001414) | 2.02899661 |
104 | Hyporeflexia of lower limbs (HP:0002600) | 2.00640379 |
105 | Hyperglycinemia (HP:0002154) | 1.97173322 |
106 | Nemaline bodies (HP:0003798) | 1.97041232 |
107 | Generalized aminoaciduria (HP:0002909) | 1.96288004 |
108 | Esophageal neoplasm (HP:0100751) | 1.95902200 |
109 | Neoplasm of head and neck (HP:0012288) | 1.95902200 |
110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95900721 |
111 | Pallor (HP:0000980) | 1.95786709 |
112 | Myokymia (HP:0002411) | 1.95606345 |
113 | Neoplasm of the adrenal gland (HP:0100631) | 1.95250611 |
114 | Sparse eyelashes (HP:0000653) | 1.93911715 |
115 | Multiple enchondromatosis (HP:0005701) | 1.93236744 |
116 | Colon cancer (HP:0003003) | 1.92830757 |
117 | Methylmalonic acidemia (HP:0002912) | 1.92592401 |
118 | Unsteady gait (HP:0002317) | 1.92065941 |
119 | Macrocytic anemia (HP:0001972) | 1.91312650 |
120 | Abnormal atrioventricular conduction (HP:0005150) | 1.89686411 |
121 | Abnormality of methionine metabolism (HP:0010901) | 1.89394177 |
122 | Atrioventricular block (HP:0001678) | 1.89276168 |
123 | Palmoplantar keratoderma (HP:0000982) | 1.85786590 |
124 | Rough bone trabeculation (HP:0100670) | 1.85765680 |
125 | Muscle stiffness (HP:0003552) | 1.84243386 |
126 | Methylmalonic aciduria (HP:0012120) | 1.84017400 |
127 | Progressive microcephaly (HP:0000253) | 1.83932064 |
128 | Abnormal pupillary function (HP:0007686) | 1.81615564 |
129 | Muscle fiber inclusion bodies (HP:0100299) | 1.80754423 |
130 | Blindness (HP:0000618) | 1.80094549 |
131 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.77882156 |
132 | Nausea (HP:0002018) | 1.76341256 |
133 | Abnormality of serum amino acid levels (HP:0003112) | 1.74776089 |
134 | Hypoglycemic coma (HP:0001325) | 1.74005818 |
135 | Muscle fiber atrophy (HP:0100295) | 1.73064942 |
136 | Gout (HP:0001997) | 1.71593975 |
137 | Opisthotonus (HP:0002179) | 1.68536007 |
138 | Microretrognathia (HP:0000308) | 1.67738716 |
139 | Metabolic acidosis (HP:0001942) | 1.67258216 |
140 | Hyperglycinuria (HP:0003108) | 1.66880732 |
141 | Cleft eyelid (HP:0000625) | 1.64156670 |
142 | Absent thumb (HP:0009777) | 1.63885884 |
143 | Type 2 muscle fiber atrophy (HP:0003554) | 1.63358183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 6.33570160 |
2 | NME1 | 3.89358825 |
3 | MYLK | 3.69463261 |
4 | NME2 | 3.45763532 |
5 | OBSCN | 3.36523575 |
6 | BCKDK | 2.97128435 |
7 | STK16 | 2.88125111 |
8 | BUB1 | 2.78541046 |
9 | PDK3 | 2.59934494 |
10 | PDK4 | 2.59934494 |
11 | CDC7 | 2.50646856 |
12 | NEK1 | 2.48597906 |
13 | LMTK2 | 2.46606668 |
14 | EIF2AK1 | 2.44761126 |
15 | TTN | 2.34939825 |
16 | PHKG1 | 2.22755542 |
17 | PHKG2 | 2.22755542 |
18 | MAP3K12 | 2.17526144 |
19 | WEE1 | 2.04646348 |
20 | PINK1 | 1.94312176 |
21 | TLK1 | 1.92109664 |
22 | GRK7 | 1.91520512 |
23 | NUAK1 | 1.72838917 |
24 | MUSK | 1.71989617 |
25 | ARAF | 1.60345380 |
26 | SRPK1 | 1.53674228 |
27 | IRAK3 | 1.51893734 |
28 | ZAK | 1.51080197 |
29 | PDK2 | 1.50247886 |
30 | WNK4 | 1.49830615 |
31 | TESK1 | 1.41014944 |
32 | STK38L | 1.40407816 |
33 | PNCK | 1.36377629 |
34 | STK24 | 1.36062845 |
35 | BRAF | 1.35729280 |
36 | CAMK2D | 1.26308519 |
37 | PLK4 | 1.25177289 |
38 | MAP3K11 | 1.23500124 |
39 | VRK1 | 1.22960188 |
40 | TAF1 | 1.22958202 |
41 | PIK3CA | 1.22152658 |
42 | CSNK1G3 | 1.21533809 |
43 | EIF2AK3 | 1.15242841 |
44 | TSSK6 | 1.14087352 |
45 | DAPK3 | 1.13387194 |
46 | CDK8 | 1.06411674 |
47 | ILK | 1.06370708 |
48 | PIM2 | 1.01065956 |
49 | ABL2 | 0.99283734 |
50 | CDK19 | 0.96543812 |
51 | GRK5 | 0.95229134 |
52 | CSNK1G1 | 0.94363470 |
53 | LIMK1 | 0.93598650 |
54 | MAP2K7 | 0.92070181 |
55 | KDR | 0.90546435 |
56 | MARK1 | 0.89140849 |
57 | MAP4K2 | 0.88688260 |
58 | CSNK1G2 | 0.88176148 |
59 | CHEK2 | 0.85866819 |
60 | ATR | 0.85855720 |
61 | CSNK1A1L | 0.84227894 |
62 | SCYL2 | 0.83242681 |
63 | CAMK2G | 0.81733997 |
64 | MAPKAPK5 | 0.80225941 |
65 | MAP3K4 | 0.80217789 |
66 | CAMK2A | 0.80110118 |
67 | AURKA | 0.80081662 |
68 | STK39 | 0.79636723 |
69 | BMPR1B | 0.77755148 |
70 | TRIM28 | 0.74096929 |
71 | MAP3K5 | 0.73370441 |
72 | MAPKAPK3 | 0.72169649 |
73 | MAP2K4 | 0.70750318 |
74 | TTK | 0.66898177 |
75 | AKT3 | 0.64881436 |
76 | PLK1 | 0.64564394 |
77 | CDC42BPA | 0.64377121 |
78 | RPS6KA5 | 0.63573171 |
79 | EIF2AK2 | 0.62597555 |
80 | CASK | 0.59612995 |
81 | PAK3 | 0.59292020 |
82 | PAK4 | 0.59160616 |
83 | TESK2 | 0.58617489 |
84 | CAMK2B | 0.58347177 |
85 | LATS2 | 0.57599898 |
86 | PRKACA | 0.57531835 |
87 | TIE1 | 0.57304817 |
88 | WNK3 | 0.56828724 |
89 | MINK1 | 0.56258000 |
90 | GRK1 | 0.54216237 |
91 | CSNK2A2 | 0.52577847 |
92 | CSNK2A1 | 0.52207206 |
93 | ADRBK1 | 0.51389124 |
94 | PRKCI | 0.50826946 |
95 | LRRK2 | 0.49620834 |
96 | INSRR | 0.49459203 |
97 | CDK7 | 0.49319969 |
98 | MAPK12 | 0.47215135 |
99 | STK4 | 0.47206296 |
100 | OXSR1 | 0.46238141 |
101 | BRSK2 | 0.45603231 |
102 | PAK1 | 0.45080534 |
103 | DYRK2 | 0.44928207 |
104 | AURKB | 0.44881508 |
105 | ROCK2 | 0.42962112 |
106 | PLK3 | 0.42808838 |
107 | CCNB1 | 0.42068176 |
108 | PLK2 | 0.41909856 |
109 | ROCK1 | 0.41828383 |
110 | PRKCG | 0.41566365 |
111 | ADRBK2 | 0.41507871 |
112 | PRKCE | 0.40540803 |
113 | CHEK1 | 0.37773000 |
114 | DAPK1 | 0.37616521 |
115 | EPHA2 | 0.35895833 |
116 | DMPK | 0.35489610 |
117 | MAP2K6 | 0.35108605 |
118 | AKT2 | 0.35095427 |
119 | RPS6KB2 | 0.35009603 |
120 | ATM | 0.33497877 |
121 | CSNK1A1 | 0.33137727 |
122 | PRKACB | 0.32700570 |
123 | PBK | 0.31983417 |
124 | MST4 | 0.31973513 |
125 | CSNK1E | 0.28304084 |
126 | MKNK1 | 0.28239333 |
127 | BRSK1 | 0.27830106 |
128 | RPS6KL1 | 0.27809808 |
129 | RPS6KC1 | 0.27809808 |
130 | CAMK1 | 0.27350026 |
131 | DYRK3 | 0.27205050 |
132 | PRKD1 | 0.26200643 |
133 | CDK1 | 0.21287405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.01183039 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.41382733 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.99408269 |
4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.88757778 |
5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.82021279 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.74542451 |
7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.42737662 |
8 | Ribosome_Homo sapiens_hsa03010 | 3.37664302 |
9 | Proteasome_Homo sapiens_hsa03050 | 3.25977260 |
10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.72518940 |
11 | RNA polymerase_Homo sapiens_hsa03020 | 2.32862499 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89655866 |
13 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84358184 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78419556 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67939088 |
16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67309093 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63780560 |
18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.44355414 |
19 | Protein export_Homo sapiens_hsa03060 | 1.37895100 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34698607 |
21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29547346 |
22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19593417 |
23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14960781 |
24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11797929 |
25 | DNA replication_Homo sapiens_hsa03030 | 1.10407432 |
26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10231202 |
27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09089804 |
28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08834394 |
29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06558894 |
30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05933433 |
31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02477907 |
32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01445604 |
33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99338829 |
34 | Mismatch repair_Homo sapiens_hsa03430 | 0.97627410 |
35 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.90271224 |
36 | Purine metabolism_Homo sapiens_hsa00230 | 0.87332026 |
37 | Spliceosome_Homo sapiens_hsa03040 | 0.84213013 |
38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80275363 |
39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79467498 |
40 | Homologous recombination_Homo sapiens_hsa03440 | 0.79188558 |
41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75709955 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74342322 |
43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74152340 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72955776 |
45 | RNA transport_Homo sapiens_hsa03013 | 0.71547831 |
46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71458368 |
47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69274559 |
48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67914627 |
49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65833623 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65338662 |
51 | Cell cycle_Homo sapiens_hsa04110 | 0.63659708 |
52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62346918 |
53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59384997 |
54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59106254 |
55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56576989 |
56 | Peroxisome_Homo sapiens_hsa04146 | 0.56419176 |
57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55160029 |
58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54410742 |
59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52651392 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51507545 |
61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51030267 |
62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49184235 |
63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46485075 |
64 | RNA degradation_Homo sapiens_hsa03018 | 0.45777268 |
65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45393228 |
66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43958103 |
67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41585314 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41302044 |
69 | Base excision repair_Homo sapiens_hsa03410 | 0.40552536 |
70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39758198 |
71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39748821 |
72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39160462 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37972498 |
74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37063580 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36704589 |
76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35675321 |
77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35330705 |
78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34940122 |
79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32981188 |
80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32508737 |
81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31500540 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29655172 |
83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28455113 |
84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28198214 |
85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27079554 |
86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25252602 |
87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24821103 |
88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.24403256 |
89 | Phototransduction_Homo sapiens_hsa04744 | 0.23487045 |
90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23428780 |
91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23374222 |
92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21581378 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21433624 |
94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.20661702 |
95 | Taste transduction_Homo sapiens_hsa04742 | 0.19148023 |
96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.17920805 |
97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.17429926 |
98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17192730 |
99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.16913385 |
100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16871054 |
101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16820108 |
102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16770023 |
103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15913413 |
104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15463124 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14533195 |
106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.14333578 |
107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.13236157 |
108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12763643 |
109 | Mineral absorption_Homo sapiens_hsa04978 | 0.12634771 |
110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.11590695 |
111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.10274326 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.10174917 |
113 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.09930208 |
114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06555661 |
115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.05918276 |
116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.04018392 |
117 | Insulin secretion_Homo sapiens_hsa04911 | 0.03049325 |
118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.02982745 |
119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02036355 |
120 | GABAergic synapse_Homo sapiens_hsa04727 | 0.01776630 |
121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01122486 |
122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.00478321 |